Cleared Traditional

K922109 - KING DIAGNOSTICS ALT (GPT) REAGENT
(FDA 510(k) Clearance)

Jun 1992
Decision
30d
Days
Class 1
Risk

K922109 is an FDA 510(k) clearance for the KING DIAGNOSTICS ALT (GPT) REAGENT. This device is classified as a Nadh Oxidation/nad Reduction, Alt/sgpt (Class I - General Controls, product code CKA).

Submitted by King Diagnostics, Inc. (Indianapolis, US). The FDA issued a Cleared decision on June 4, 1992, 30 days after receiving the submission on May 5, 1992.

This device falls under the Chemistry FDA review panel. Regulated under 21 CFR 862.1030.

Submission Details

510(k) Number K922109 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 05, 1992
Decision Date June 04, 1992
Days to Decision 30 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code CKA — Nadh Oxidation/nad Reduction, Alt/sgpt
Device Class Class I - General Controls
CFR Regulation 21 CFR 862.1030

Similar Devices — CKA Nadh Oxidation/nad Reduction, Alt/sgpt

All 126
HITACHI CLINICAL ANALYZER S TEST REAGENT CARTRIDGE ALT, HITACHI CLINICAL ANALYZER S TEST REAGENT CARTRIDGE AST
K120945 · Hitachi Chemical Diagnostics, Inc. · Jun 2013
ACE ALT REAGENT
K113382 · Alfa Wassermann · Jul 2012
DIMENSION VISTA ALBUMIN, ALKALINE PHOSPHATASE, ASPARTATE AMINO TRANSFERASE, CARBAMAZEPINE & ALANINE AMINO TRANSFERASE
K061020 · Dade Behring, Inc. · May 2006
CARESIDE ALT
K020487 · Careside, Inc. · Jun 2002
ALT (GPT) LIQUID STABLE 2 VIAL - INCORPORATING DYNAMIC STABILIZATION TECHNOLOGY - (DST)
K980028 · Trace America, Inc. · Feb 1998
TRACE REAGENT LINE FOR THE COBAS MIRA
K973869 · Trace America, Inc. · Jan 1998